Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surrey Capital Partners is a private life sciences-focused investment firm and healthcare innovation fund based in New York. The firm was founded by Samantha Surrey and is described by multiple sources as investing in biotech, healthcare, and medical device companies, particularly early- to mid-stage opportunities. Public descriptions emphasize access to a pipeline of biotech and healthcare companies and an interest in life-changing devices and health innovation. Available sources indicate it operates as an investor rather than a drug-development company, so it does not appear to maintain an internal therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surrey Capital Partners.